GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Notes Receivable

Kineta (STU:J75) Notes Receivable : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Notes Receivable?

Kineta's Notes Receivable for the quarter that ended in Mar. 2024 was €0.00 Mil.


Kineta Notes Receivable Historical Data

The historical data trend for Kineta's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Notes Receivable Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Notes Receivable
- - - -

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kineta Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Kineta Notes Receivable Related Terms

Thank you for viewing the detailed overview of Kineta's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta (STU:J75) Business Description

Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines